These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 25497511)
1. QTc prolongation and haloperidol: just how risky is this drug? Howland RH Psychosomatics; 2014; 55(6):741-2. PubMed ID: 25497511 [No Abstract] [Full Text] [Related]
3. Consideration of the JT interval rather than the QT interval. Salik J; Muskin PR Psychosomatics; 2013; 54(5):502. PubMed ID: 24034531 [No Abstract] [Full Text] [Related]
4. Prolongation of QTc interval and antipsychotics. Su KP; Chang HC; Shen WW Am J Psychiatry; 2002 Jun; 159(6):1062-3; author reply 1064. PubMed ID: 12042204 [No Abstract] [Full Text] [Related]
5. Probable Acquired QTc Prolongation and Subsequent Torsades de Pointes Attributable to Quetiapine. Giancaterino S; Solimine S Prim Care Companion CNS Disord; 2017 Nov; 19(6):. PubMed ID: 29190419 [No Abstract] [Full Text] [Related]
6. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly. Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic drugs and QT interval prolongation. Zareba W; Lin DA Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603 [TBL] [Abstract][Full Text] [Related]
9. Drug induced QT prolongation and torsades de pointes. Yap YG; Camm AJ Heart; 2003 Nov; 89(11):1363-72. PubMed ID: 14594906 [No Abstract] [Full Text] [Related]
10. [Antipsychotic pharmacotherapy for delirious syndromes - only temporary, symptom-oriented and considering QTc time]. Schwerthöffer D; Förstl H; Fatke B MMW Fortschr Med; 2019 Jul; 161(Suppl 5):1-6. PubMed ID: 31313266 [TBL] [Abstract][Full Text] [Related]
11. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction. Michalets EL; Smith LK; Van Tassel ED Ann Pharmacother; 1998; 32(7-8):761-5. PubMed ID: 9681092 [TBL] [Abstract][Full Text] [Related]
12. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium. Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342 [TBL] [Abstract][Full Text] [Related]
13. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol. Muzyk AJ; Rayfield A; Revollo JY; Heinz H; Gagliardi JP Drug Saf; 2012 Jul; 35(7):547-53. PubMed ID: 22702639 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Haddad PM; Anderson IM Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926 [TBL] [Abstract][Full Text] [Related]
15. [QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline]. Züchner H Dtsch Med Wochenschr; 2002 May; 127(18):983-4. PubMed ID: 11987023 [No Abstract] [Full Text] [Related]
16. [QTc-prolonging drugs and the risk of sudden death]. Reingardiene D; Vilcinskaite J Medicina (Kaunas); 2007; 43(4):347-53. PubMed ID: 17485963 [TBL] [Abstract][Full Text] [Related]
17. Emergency department approach to QTc prolongation. Pourmand A; Mazer-Amirshahi M; Chistov S; Sabha Y; Vukomanovic D; Almulhim M Am J Emerg Med; 2017 Dec; 35(12):1928-1933. PubMed ID: 28855066 [TBL] [Abstract][Full Text] [Related]
18. Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index. Mukherji EH; Bauer LK; Leskov I; Januzzi JL; Tanev KS Am J Psychiatry; 2011 Sep; 168(9):990-1. PubMed ID: 21890808 [No Abstract] [Full Text] [Related]